
Microtransistors de grafè: una tecnologia d'ample de banda per registrar potencials de camp cerebral
Informació básica
Eduard Masvidal Codina
2021
Jose A. Garrido Ariza Anton Guimerà Brunet
Premi
Masculí
ICN2
Universitat Autònoma de Barcelona (UAB)
Institut CERCA

Cerdanyola del Vallès, Spain
2004
Institut Català de Nanociència i Nanotecnologia (ICN2)
Suport

Barcelona, Spain
2019
INBRAIN NEUROELECTRONICS SL
Àrea
Materials avançats
BioTech
IoT & Sensors
Medtech
Salut i Medicina
Indústria
Electrònica
Tecnologies de la informació i la comunicació
Resum
Els enregistraments d'activitat neuronal d'alta densitat són vitals en la recerca centrada en descobrir els processos subjacents de les funcions i patologies cerebrals complexes; tenen aplicacions en el diagnòstic mèdic, el pronòstic i el seguiment del tractament i són la base de les neuropròtesis sanitàries. Tanmateix, les tecnologies actuals d'enregistrament electrofisiològic no compleixen tots els requisits d'una interfície neuronal robusta i d'alta fidelitat. En particular, una limitació actual de les matrius de microelèctrodes, a causa de la reactivitat electroquímica dels materials i/o l'alta impedància, és la dificultat per mesurar l'activitat infralenta (ISA, ≈ < 0,1 Hz), important en estats fisiològics i patologies com el dany cerebral o l'epilèpsia. En aquesta tesi doctoral, s'han desenvolupat interfícies neuronals flexibles basades en transistors de grafè (gSGFET) i s'ha estudiat el seu ús per al registre d'activitat neuronal comparant-les amb les tecnologies actuals d'avantguarda. Els resultats obtinguts demostren que la tecnologia gSGFET supera les limitacions dels enregistraments passius actuals de microelèctrodes per al registre ISA. També es demostra la compatibilitat de la tecnologia gSGFET amb les neurotecnologies actuals com l'optogenètica i les tècniques d'imatge cerebral. En general, la tecnologia de gSGFETs desenvolupada és madura i està llesta per ser adoptada pels laboratoris de recerca, amb un potencial especial per a la recerca translacional bàsica i preclínica. Un major desenvolupament tecnològic centrat en la traducció clínica dels dispositius podria aportar els beneficis d'una millor monitorització de la fisiologia cerebral als pacients.
for the mapping of infraslow activity and potential for clinical translation (Hartings, 2019). Although infraslow signals have been regarded as unwanted noise in the past, due to the difficulties in their measurement, there is now increasing appreciation that they reflect important neural processes that are relevant to both normal cognition and disease states, such as stroke, traumatic brain injury or epilepsy. The developed technology has high commercial interest. The intellectual property behind the fabrication methodology has been protected under an industrial secret while the methodology for obtaining wide-band high-quality recordings has been patented WO2020094898 (Guimera Brunet et al., 2018). This patent has been licensed for commercialization to a company specialized in the pre-clinical neurotechnology sector (Multichannel Systems, MCS) and is also under negotiation for licensing with a company focused on clinical translation of the technology (INBRAIN). The technology transfer performed ensures the applicability of the developed technology. Particularly, MCS is expected to launch a commercial product based on this technology in 2022, and INBRAIN foresees huge clinical potential (see letters of interest and Table 2). Moreover, further improvement and refinement of the technology is being carried out by the Graphene Flagship Core3 project. For the example, the usefulness of the technology for epilepsy research has been recently investigated(Calia et al., 2021). A project proposal to the European EIC Transition project call with participation of INBRAIN has also been submitted “Towards clinical translation of graphene-based active sensors for wide bandwidth brain mapping”. The gSGFET technology developed during the thesis is mature and will be available to be adopted by research laboratories, thanks to the commercial launch by MCS in the near future, while the human application in clinical neurophysiology is planned to be pushed by INBRAIN. Altogether, this will allow to have impact both in basic and pre-clinical neuroscience research as well as in the clinics for an improved neurophysiology monitoring.
High-Density Neural Activity Recordings; Complex Brain Functions; Brain Pathologies; Medical Diagnosis; Prognosis; Treatment Monitoring; Healthcare Neuroprostheses; Electrophysiological Recording Technologies; Robust Neural Interface; High-Fidelity Neural Interface; Microelectrode Arrays; Electrochemical Reactivity; High Impedance; Infraslow Activity (ISA); Physiological States; Brain Damage; Epilepsy; Flexible Neural Interfaces; Graphene Transistors (gSGFETs); Neural Activity Recording; State-of-the-Art Technologies; Passive Microelectrode Recordings; Optogenetics; Brain Imaging Techniques; Research Laboratories; Basic Research; Preclinical Translational Research; Clinical Translation; Brain Physiology Monitoring.